entertainment -WSS

entertainment

author：knowledge 2025-09-30 12:08:50 - browse：43778

The FDA building -- First Opinion coverage from STAT — Adobe

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine.

The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators. But in approving the drug for the treatment of fibrodysplasia ossificans progressiva, or FOP, the Food and Drug Administration concluded that Sohonos’ benefits outweigh its risks.

“I just closed my eyes and looked up to the skies, like ‘Thank you, God,’” said Suzanne Hollywood, whose teenage son, Joey, has been receiving the drug in a clinical trial. “It’s far from perfect, but I’m thrilled for my son, for his future, and for the kids getting diagnosed who might not have to experience what others had to.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： NVIDIA and Google execs on the future of AI and drug discovery

WSS

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

R1 RCM gets $5.8 billion buyout offer from private equity firm

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Readout LOUD podcast: Live from STAT Breakthrough Summit West

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

A new nitrogen execution bill also undermines medical licensing

focus

entertainment

knowledge

Medical records are filled with copy

PBM reform efforts get punted in Congress

The cancer drug shortage isn’t new — and neither are the solutions

PBM reform efforts get punted in Congress

State Dept. review finds Biden bears some blame for Afghanistan failures

When prostate cancer spreads, where it goes matters

Malaria cases in Florida and Texas: Here’s what you need to know

Alabama frozen embryo ruling has major implications for IVF clinics

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT readers on older presidents, polypills, Medicare, and more

knowledge

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Big Tobacco's 'harm reduction': Is it for real, or a sham?

A new nitrogen execution bill also undermines medical licensing

Dario to buy mental health app maker Twill in cash and stock deal

Addiction experts warn against a second 'war on drugs'

hotspot

hotspot

focus

focus